Diabetes treatment via m-health

MUMBAI, INDIA: Brighter, a Stockholm-based healthcare provider wanted to standardize solutions using device connection platform (DCP) and leverage it for lifecycle management, control and distribution of its connected device for diabetes treatment that combines blood sugar measurement and insulin injection capabilities.

Truls Sjöstedt, CEO, Brighter, added, “Connected solutions such as next generation Brighter One can be integrated into Brighter’s platform The Benefit Loop, in which patient data is continuously combined with additional relevant data to improve treatment and quality of life.”

DCP is a cloud-based Internet of Things (IoT)/machine-to-machine (M2M) platform that handles connectivity management, subscription management and OSS/BSS, enabling automation of business processes between operators and enterprises.

Anders Olin, Vice President, Product Area Network Functions, Business Unit Cloud & IP, Ericsson, said, “In today’s competitive ICT industry, operators can benefit from providing e-health services alongside traditional voice and data offerings. This collaboration combines the DCP with Brighter’s connected products, which can create new growth opportunities for global operators, as well as having a positive impact on patient health.”

According to the World Health Organization, in 2014, 9 percent of adults worldwide aged 18 years or older had diabetes. In 2012, diabetes was the direct cause of 1.5 million deaths, and the disease is projected to become the seventh-leading cause of death by 2030.